DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) NBIX Holdings History
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s Neurocrine Biosciences Inc Holding Summary
As of 2025-03-31, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) held 1.49 Mil shares of Neurocrine Biosciences Inc(NBIX), totaling $164.68 Mil. This investment constitutes 3.71% of their stock portfolio, and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) now holds 1.5% of the outstanding Neurocrine Biosciences Inc(NBIX) stock.
The initial trade took place in 2014Q1. And since then DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) has made 9 purchases of NBIX, at an average price of $107.49, for a total of 3.58 Mil shares. In addition, there have been 7 sales at an average price of $107.66 for 2.09 Mil shares. Based on historical transaction data and NBIX's current price of $133.66, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s estimated gain on his NBIX holdings is $39.32 Mil, reflecting a 10.23% gain to date.
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) NBIX ($133.66) Holding Chart
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) NBIX ($133.66) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
